Medicamen Biotech Ltd. — Director's Dealing 2021

Dec 21, 2021

IEDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)

Tel.: 011 - 47589500-51 (50 Lines), E-mail: info@medicamen.com Web: www.medicamen.com CIN No.: L74899DL1993PLC056594

Dated: 21.12.2021

To, BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001

National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

Scrip Code: 531146

Subject: Intimation as per Regulation $7(2)(b)$ of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam.

Please find attached disclosure dated December 21, 2021 in Form-C pursuant to Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Growel Remedies Limited for sale of 1,576 Equity Shares from the open market.

We request you to treat this intimation as compliance with Regulation $7(2)$ (b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and take the same on record.

$\chi_{\rm{max}}=0$

For Medicame Biotech Limited

Coque Parul Choudhary Company Secretary

ACS: 44157

Encl: A/a

Dated: 21.12.2021

To, The Compliance Officer Medicamen Biotech Limited 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, 110019

Subject: Submission of disclosure under Regulation $7(2)(a)$ read with regulation $6(2)$ of SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam,

With reference to the above captioned subject, we would like to apprise you that Growel Remedies Limited (Promoter of Medicamen Biotech Limited ("Target Company") has sold 1,576 Equity Shares of Rs. 10/- each through the open market.

In this connection please find enclosed the required disclosure.

You are requested to take the above information on your records and inform the exchange accordingly.

For Growel Remedies Limited

Rahul Bishnoi Director DIN: 00317960

Encl: A/a

Name of the company: Medicamen Biotech Limited ISIN of the company: INE646B01010

[Regulation 7 (2) read with Regulation $6(2) -$ Continual disclosure] SEBI (Prohibition of Insider Trading) Regulations. 2015 FORM C

l,

Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other
such persons as mentioned in Regul

market/public acquisition / disposal (on preferential Mode of rights/	market/Inter- offer / off transfer. ESOP s etc.) Se S	On Market $\begin{bmatrix} \mathbf{1}{\mathbf{1}{\mathbf{1}}} & \mathbf{1}{\mathbf{1}{\mathbf{1}}} \ \mathbf{1}{\mathbf{1}{\mathbf{1}}} & \mathbf{1}{\mathbf{1}{\mathbf{1}}} \ \mathbf{1}{\mathbf{1}} & \mathbf{1}{\mathbf{1}} & \mathbf{1}_{\mathbf{1}} \end{bmatrix}$
intimation company Date of $\ddot{c}$		21.12.2021
	ρ	20.12.2021
disposal of shares Date of allotment aequisition of advice/ shares/ specify	From	20.12.2021
acquisition/disposal Securities held post	shareholding No. and % $\sigma$ f	equity shares $(2.46\%)$ 3.00,000
	(For eq. Debenture Rights Convertib Warrants. entitleme security Type of Shares. nt. etc.) i S $\overline{2}$	Equity Shares
	Purchase Invecatio Transact Revoeati specify) Pledge- Others- please Type /sale $\overline{5}$ \$ $\sharp$	Sale
	Value (In Rs.)	(Rupees I welve Lakhs Eighty Five Thousand and Vineteen only/-) Rs. 12.85.019
Securities aequired/Disposed	ò. Z	Equity Shares 1.576
	sharehold (For eg. s. Converti security Type of Warrant etc.)etc.) Debentu Rights entitlem Shares. ents ble res	Equity Shares
	and % Σ. of	3.01.576 $(2.47\%)$ equity shares
aequisition/disposal Securities held prior to	entitlements Convertible Debentures Warrants . - Shares. Type of security (For cg. Rights etc.	Equity shares
member of Category of group/desig (Promoter/ promoter Person the	s/immediate to/others Director relative person/ nated ctc.)	Promoter (dno.fa)
& address CIN/DIN. contact Name, PAN. with nos.		Growel Wellness Innovations Ltd.) $No.$ : Tower 43, Nehru +919810739079 Name: Growel Address: 1506. AABCG3108P Place, New Delhi-110019 Remedies (formerly) Chiranjiv Contact Limited PAN:

Note: "Securities" shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

	Trading in	n derivatives (Specify type of contract. Futures or Options etc)				Exchange on which the trade was
			Buy.			executed
					ಸ
Type of	Contract		Number of units
contract	specifications	Notional Value	(contracts * lot	Notional Value	Number of units
			size)		(contracts * lot size)
		$\sum_{i=1}^{n}$	$\breve{\ge}$	$\frac{\triangleleft}{\triangle}$	Ź	$\breve{\ge}$
	Note: In case of Options, notional value shall	be calculated based on Premium plus strike vrice of options

ś. $\overline{a}$

Yours faithfully

For Growel Remedies Ltd

e
S 76J RIEL

Director
DIN: 00317960 RahutBishnoi

Place: New Delhi Date: 21.12.2021

*******